Brief: Transgene Strengthens Global IP Protection For Its Novel Invir.IO™ Oncolytic Viruses Encoding Immune Checkpoint Inhibitors (ICIs)

Transgene SA

08/06/2021 17:05

June 8 (Reuters) - Transgene SA  TRNG.PA :
    * TRANSGENE STRENGTHENS GLOBAL IP PROTECTION FOR ITS NOVEL
INVIR.IO™ ONCOLYTIC VIRUSES ENCODING IMMUNE CHECKPOINT
INHIBITORS (ICIS)
    * THESE PATENTS PROTECT TRANSGENE'S VV(COP)TK(-)RR(-)
BACKBONE
ENCODING ONE OR SEVERAL ICIS UNTIL 2035
    * APPLICATIONS ARE PENDING IN CANADA AND IN CHINA

Source text for Eikon:  ID:nBw67tFdRa 
Further company coverage:  TRNG.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))